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Abstract
A measurement is always afflicted with some degree of uncertainty. A correct understanding of the different types of 
uncertainty, their naming, and their definition is of crucial importance for an appropriate use of the measuring instruments. 
However, in perioperative and intensive care medicine, the metrological requirements for measuring instruments are poorly 
defined and often used spuriously. The correct use of metrological terms is also of crucial importance in validation studies. 
The European Union published a new directive on medical devices, mentioning that in the case of devices with a measuring 
function, the notified body is involved in all aspects relating to the conformity of the device with the metrological require‑
ments. It is therefore the task of scientific societies to establish the standards in their area of expertise. After adopting the 
same understandings and definitions (part 1), the different procedures for the validation of major quality criteria of meas‑
uring devices must be consensually established. In this metrologic review (part 2), we review the terms and definitions of 
validation, some basic processes leading to the display of an indication from a physiologic signal, and procedures for the 
validation of measuring instrument properties, with specific focus on perioperative and intensive care medicine includ‑
ing appropriate examples.
Keywords Statistics · Critical care · Perioperative medicine · Hemodynamic monitoring · Cardiovascular dynamics
 * Thomas W. L. Scheeren 
 t.w.l.scheeren@umcg.nl
1 Department of Cardiology and ICU, Clinique Ambroise 
Paré, Neuilly‑sur‑Seine, France
2 Department of Anesthesiology, University of Groningen, 
University Medical Centre Groningen, Groningen, 
The Netherlands
3 Intensive Care, St Georges’ University Hospitals NHS 
Foundation Trust, London, UK
4 Departmento de Medicina Intensiva, Facultad de Medicina, 
Pontificia Universidad Católica de Chile, Santiago, Chile
5 Department of Intensive Care Adults, Erasmus MC 
University Medical Center, Rotterdam, The Netherlands
6 Department of Pulmonary and Critical Care, New York 
University, New York, USA
7 Division of Pulmonary, Allergy, and Critical Care Medicine, 
Columbia University Medical Center, New York, USA
8 Department of Anesthesia and Critical Care, Humanitas 
University, Milano, Italy
9 General Intensive Care Unit of the Shaare Zedek Medical 
Centre, Hebrew University Faculty of Medicine, Jerusalem, 
Israel
10 Department of Intensive Care, University Hospital Brussels 
(UZB), Jette, Belgium
11 Faculty of Medicine and Pharmacy, Vrije Universiteit 
Brussel (VUB), Brussels, Belgium
12 Medical Intensive Care Unit, Paris‑Sud University Hospitals, 
Assistance Publique‑Hôpitaux de Paris, Inserm UMR S_999, 
Le Kremlin‑Bicêtre, France
13 Department of Anesthesiology and Intensive Care Medicine, 
University Medical Center Rostock, Rostock, Germany
14 Department of Intensive Care, Maastricht University Medical 
Center+, Maastricht, The Netherlands
15 Department of Anesthesiology, Center of Anesthesiology 
and Intensive Care Medicine, University Medical Center 
Hamburg‑Eppendorf, Hamburg, Germany
16 Outcomes Research Consortium, Cleveland, OH, USA
 Journal of Clinical Monitoring and Computing
1 3
Abbreviations
σ  Standard deviation
SEM  Standard error of the mean
SpO2  Arterial oxygen saturation (obtained by pulse 
oximetry)
SvO2  Mixed venous oxygen saturation
FiO2  Fraction of inspired oxygen
ISO  International Organization of Standardization
1 Introduction
Verification is a provision of objective evidences that a given 
measuring instrument fulfills specified requirements [1]. 
Validation is a verification, where the specified requirements 
are adequate for the intended use [1]. Therefore, validat‑
ing measuring instruments mandates to determine first the 
intended use. In perioperative and intensive care medicine, 
we are basically measuring different quantities coming from 
the patient with basically three main objectives
(1) Monitoring: For monitoring purposes, we track the 
indication of a quantity value. When the quantity 
value changes and is outside a specified range it usu‑
ally triggers an alarm. For example, we can decide that 
a systolic blood pressure value higher than 160 mmHg 
or lower than 90 mmHg triggers an (acoustic and/or 
visual) alarm.
(2) Diagnosis and prognosis: For these purposes, we com‑
pare the indication of a quantity value to its expected 
range, with specified uncertainty. For example, we can 
assume that a normal  SpO2 is 96–100%, measured with 
± 2% uncertainty using a given measuring instrument, 
so that the diagnosis of hypoxemia is generally deter‑
mined by an  SpO2 < 94%.
(3) Therapy: For therapeutic purposes we look at improv‑
ing the indication of a quantity value up or down to a 
predetermined target value. For example, in a specific 
patient, we can decide to titrate  FiO2 to reach and main‑
tain a  SpO2 > 94%.
These three objectives need acceptable instrumental 
properties but priorities can be made according to the 
objective. For monitoring purpose, indications are com‑
pared to their initial value, measured under similar condi‑
tions, and the delay for indicating significant directional 
changes generally matters. Therefore, instrumental preci‑
sion, step response time (all linked to random errors of 
measurements), and stability are the first priorities. In 
contrast, for diagnostic and therapeutic purposes, since 
the measurand is compared with a predetermined absolute 
value, usually established from a reference method, the 
indication must be as close as possible to the true value (in 
the measuring interval). Therefore, instrumental bias, sen‑
sitivity (all linked to systematic errors of measurements), 
and their stability are the first priorities. For all purposes, 
selectivity is necessary.
Although not impossible, it is not usual to imagine 
promoting and validating a measuring instrument for a 
restricted use only (e.g., monitoring, diagnosis, or ther‑
apy). Consequently, the manufacturers of measuring 
instruments most often try to reach an acceptable com‑
promise between the different instrumental properties (i.e., 
optimal compensation of systematic and random errors). 
However, until now, no consensual independent valida‑
tion procedure addressing all these properties has been 
suggested. It is the task of a scientific society to promote 
the standards and to suggest such independent validation 
procedures.
2  How is an indication obtained?
For a better understanding of the validation procedure 
requirements, it is necessary to share some basics on the 
main processes leading to the display of an indication from 
a physiologic signal (Fig. 1). Although they may have an 
impact on measurement errors, electronic processes not 
related to the physiologic signal such as power supply 
(excitation), electric isolation, compensation, or multiplex‑
ing are not within the scope of this document.
Sensor / 
Transducer
Measurand
Signal
conditioner
Signal
calibration
Indication
Physiological signal
Very small DC current, voltage or AC signal
Measurable voltage
Value in appropriate unit
Fig. 1  Schematic steps of the signal processing from the physiologi‑
cal signal to the measuring instrument indication
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2.1  Sensing
In medicine, most measurements start from a patient’s 
physiological signal analyzed by a sensor (rarely a detector 
which has only a binary response: present or not). Whatever 
the sensed physiological signal (electric waveform, tem‑
perature, flow velocity, pressure, tension, light absorption, 
sound, electrochemical reaction…), it usually transforms a 
constant electric current in a time‑varying electric voltage 
(or conversely), allowing easier signal conditioning, which 
precludes quantitative analyses.
Example The arterial blood pressure signal (hydrostatic 
pressure signal) can be conducted by an arterial catheter and 
a fluid‑filled tubing system from the artery to a sensor (for 
example quartz resonator changing frequency in response to 
stress) where it is transduced in an electric signal.
2.2  Signal conditioning
The analog electrical output of a sensor‑transducer is usually 
small in value and has non‑idealities. The different steps of 
the signal conditioning aim at minimizing these non‑ideal‑
ities to make the signal representative of the physiological 
phenomenon and suitable for measurements. The objective 
is basically to increase as much as possible the signal‑to‑
noise ratio. The different steps listed below are schematic 
and can be combined in various sequences.
2.2.1  Amplification
The analog output signal of a sensor‑transducer is usually 
rather small in amplitude. Amplification will increase the 
amplitude/resolution of the signal to facilitate further analy‑
sis (Fig. 2). The tuning of output/input amplitude ratio is 
called span or gain adjustment.
2.2.2  Filtering
Physiological signals are always corrupted by noises of 
various origin. The 50/60 Hz AC power lines are only the 
most common. Additive noise may come from other electric 
devices and patient‑associated factors such as activity, respi‑
ration, heart rate, or high‑frequency muscle contraction. In 
contrast to external noise (not due to the measuring system), 
internal noise results from the intrinsic technology. The aim 
of filtering is to remove as much as possible the noise and 
to keep as much as possible the pure physiological informa‑
tion to be measured. Choosing the appropriate filtering is 
dependent of the nature of both physiological signal and 
noise and it is a science on its own. A common example 
is the discrete‑time Fourier transformation which enables 
to decompose any periodic signal into a set of sine waves, 
allowing to analyze the signal, not only in the time domain 
but also in the frequency domain. This may help in selecting 
the appropriate filtering methods (Fig. 3).
2.2.3  Linearization
Often, sensors do not have a linear relationship between the 
input physiological signal and the output voltage signal. The 
principle of linearization is to determine the relationship 
between the signal value and the quantity it is measuring, 
then to pass the signal through a circuit (or a mathematic 
formula) that has a response inverse to that of the meas‑
urement methodology. For example, if the transducer has 
an exponential response, its output signal might be passed 
through a mathematical formula/circuit that has a logarith‑
mic response.
2.2.4  Analog‑to‑digital conversion
At any point of the signal processing that may be found 
optimal, a step of analog‑to‑digital signal conversion can be 
required to perform appropriate treatment using software 
and firmware, for communication, display, and storage of 
the information.
2.3  Calibration
The signal needs then to be expressed proportionally and 
in the same units than the sensed quantity. In addition, the 
accuracy of all devices degrades over time due to the physi‑
ological response to the measuring system (clotting, fibrin 
1
0
signal
Time
Fig. 2  Schematic representation of amplification. In green the origi‑
nal transducer output is shown, with a signal‑to‑noise ratio = 10. The 
change of the signal represented in the middle of the figure is below 
the resolution of the analog‑to‑digital converter (with schematically 
0,1 response represented by the red dotted line). In blue, the signal 
has been amplified (x5). The change of the signal can be perceived by 
the analog‑to‑digital converter. Since the noise (external noise) is not 
amplified, the signal‑to‑noise ratio is also improved by a factor of 5, 
allowing easier filtration
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deposit,…), instrumental drift, electric or mechanical shock, 
or a hazardous manufacturing environment. As described 
previously, calibration is a traceable comparison between a 
standard measurement and the device indication. The uncer‑
tainty of the measurement standard should be small, typi‑
cally 10 times the accuracy of the test device. However, a 
ratio of 3:1 is acceptable for most standards organizations. 
Calibration is specific to each device. It may be expressed 
by a statement, calibration function, calibration diagram, 
calibration curve, or calibration table. Although strictly 
speaking it is a distinct process, in practice, calibration also 
includes the adjustment of the test device if necessary. A 
report is provided by the calibration expert, which shows 
the error in measurements with the measuring device before 
and after the calibration‑adjustment. The adjustment has two 
basic steps schematized by drawing the calibration curve, 
plotting the measurement standard values on the x‑axis and 
the test device on the y‑axis. In the theoretical situation of 
a perfect reference method, the offset is the y‑intercept, and 
the span is the regression slope, ideally tuned to 1 by ampli‑
fication (Fig. 4). It is important to notice that calibration can 
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Fig. 3  Schematic representation of Fourier filters. On the left, the 
black curve in the upper panel shows an example of periodic output 
current coming from a gauge measuring radial artery blood pres‑
sure. It can be mathematically decomposed into a very simple Fourier 
series of one fundamental sine wave (first harmonic) with a frequency 
of 1 Hz (blue curve), its second harmonic (2 Hz, green curve), and 
a high‑frequency harmonic (frequency 50 Hz, in red), figuring an 
example of noise. The 1 Hz fundamental sine wave indicates that 
the heart rate is at 60 beats/min. If it was 90 or 120 beats/min, this 
fundamental sine wave would be 1.5 or 2 Hz, respectively. Similarly, 
it would be the fundamental sine wave, of all physiological vari‑
ables related to heart contraction. In the lower panel, the frequency 
spectrum of the black curve can be created by plotting each sine 
wave amplitude in the y‑axis and its frequency on the x‑axis. Differ‑
ent electronic filters (low pass, high pass, band pass, band stop) may 
be applied to remove the energy of unwanted frequencies. The open 
box in dotted line shows the example of a low‑pass filter allowing 
frequencies of 1–3 Hz and eliminating higher frequencies. The grey 
curve on the upper panel shows the blood pressure signal after filtra‑
tion (presented with an offset for readability). On the right, the same 
representation and filtering for an example of left atrial pressure  is 
shown. The decomposition results in three harmonics (1 Hz blue, 2 
Hz green, 3 Hz purple), instead of 2. The noise (red curve) can also 
be decomposed in three components (only shown in the lower panel 
for clarity: 4 Hz red, 5 Hz orange, and 50 Hz red). a, c, v figure the 
main hemodynamic atrial waves: a, systolic contraction; c, isovolu‑
mic ventricular contraction; v, venous filling
Offset
Span 
Tested device Identy lineSlope = 1
Reference method
Fig. 4  Schematic representation of offset and span for the adjustment 
of a measuring system
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only minimize systematic errors (improve trueness) and has 
no influence on random errors (precision).
2.4  Averaging
Any indication given by a measuring device is most often the 
result of a combination of numerous sensed measurements 
during a specified period of time. For example, the heart 
rate in beats per minute can be determined by measuring 
the delay in milliseconds between two heartbeats and then 
by dividing 60,000 by this delay. Alternatively, the heart 
beats may be counted during a 10‑s interval and the obtained 
number multiplied by 6. Depending on the physiologic sig‑
nal to be measured, the time sampling may range from sev‑
eral milliseconds to several seconds. However, from these 
elementary measurements to the final indication displayed 
on the screen of the measuring device, different methods 
of averaging may be applied. To stick to the example of the 
heart rate, an indication changing on a monitor with every 
beat may be uncomfortable to read for medical caregivers. It 
can be preferable to make an averaging of the beat‑by‑beat 
analysis to refresh the indication less frequently. Moreover, 
to smooth this averaged value, the averaged sample may take 
into consideration the preceding results (moving average). 
There is a huge number of averaging methods, using math‑
ematic or algorithmic tools, but averaging is always associ‑
ated with a loss of information.
Finally, after appropriate calibration and adjustment, the 
metrological properties of a measuring device depend on the 
combined uncertainty of each elementary measurement, the 
sampling time, and the averaging method. The final compro‑
mise is always aimed at compensating the intrinsic limita‑
tions of the device. Basically, when the physiological signal 
sensed by the measuring system is poorly linked with the 
measurand, the precision of measurements is low, leading to 
an increase in sampling time and to the use of sophisticated 
averaging methods. This is always at the expense of resolu‑
tion and step response time.
Example If elementary minute‑measurements of blood 
flow decrease linearly from 6.0 to 4.0 L/min (6.0, 5.9, …, 
4.0), a 20% decrease in blood flow is indicated in 7 min 
when there is no averaging (5.4 vs. 6) or in 8, 9, 12 min 
when 3‑, 5‑, and 10‑min moving arithmetic averaging is 
used.
3  Validation procedures
Regulatory requirements for labeling measuring instru‑
ments [CE marking for countries within the European 
Economic Area (i.e., States of the European Union plus 
Iceland, Norway, Liechtenstein, Switzerland and Turkey) 
or US Food & Drug Administration approval] are intended 
to assure the safety, effectiveness, and proper labeling of 
medical devices, in order to control exposure to potentially 
hazardous events, and to ensure the safe, efficacious use 
of such devices. The International Organization for Stand‑
ardization (ISO) mandates that each manufacturer deter‑
mines an intended purpose and ensures that the device is 
suitable for its intended purposes and capable of producing 
valid measurement results. However, for measuring instru‑
ments in perioperative and intensive care medicine, there 
is no independent definition of what is a “valid” result in 
clinical practice.
3.1  Reference measurement procedure
For each specific measurand, a reference measurement 
procedure, usable in clinical conditions, must be identified. 
The reference measurement procedure must be recently 
and appropriately calibrated in an official national refer‑
ence laboratory, used in the appropriate conditions and in 
its validated measuring interval. Its uncertainty must be 
known, traceable, and presumably small as compared to 
the uncertainty of the test device.
For example, for testing a new device for cardiac out‑
put assessment, an artificial heart or an extra‑corporeal 
pump with a measurable flow may be chosen for giving 
a reference. If the test device requires a beating heart, an 
ultrasonic flow probe positioned around the pulmonary 
artery or the aorta during an open chest surgery may be 
preferred. If the test device requires a closed chest and 
standard clinical conditions, the dilution of a bolus indica‑
tor may be chosen. Most often, the reference value of the 
measurand is obtained by averaging several measurements 
from the reference procedure. The appropriate number of 
replicates must be chosen for reaching, at least, an uncer‑
tainty four times less than that of the test device (prefer‑
ably ten times).
The number of replicate measurements with the refer‑
ence method needed to derive the reference value of the 
measurand with the prescribed uncertainty is determined 
by the standard error of the mean (SEM) according to the 
formula: 2 SEM = 2 σ/
√
n if the uncertainty is limited to 
imprecision. For example, if the test device has a presum‑
able imprecision of 20% for determining cardiac output, 
the reference value must at least have an imprecision ≤ 5% 
(four times less), and preferably ≤ 2% (ten times less). 
Therefore, if the reference method has an imprecision of 
10% (2σ), then the reference value (estimated true cardiac 
output) must average at least 4 reference measurements 
(objective = 5%, obtained by SEM = 10%/
√
4 ). Preferably, 
25 reference measurements must be averaged to reach a 
SEM = 10%/
√
25 = 2%. Theoretically, a reference method 
can be found from continuous measurements if the high 
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variability can be compensated by the large amount of 
data collected, therefore leading to an acceptable SEM [2].
3.2  Constancy of the measurand
A measurement procedure takes a certain amount of time. 
The imprecision inherent to all measurements mandates 
averaging several measurements to determine the reference 
value and the tested quantity value of the measurand. During 
the collection of all the needed measurements, the measur‑
and must be as constant as possible. If this is not the case, 
the dispersion of the measurand adds another dimension of 
uncertainty [3].
3.3  The test device: estimation of measurements 
properties
In a unique patient in hypothetical clinical steady state, the 
needed number of replicate measurements must be per‑
formed using the reference method and the test device in 
parallel, during a short period of time. If we theoretically 
assume that during a stable, short period of time, the meas‑
urand is constant, the appropriate number of replicate val‑
ues obtained from the reference method gives the reference 
value (or estimated true value, T) and its variability (2σref) 
due to random errors that may be called instrumental preci‑
sion or uncertainty of the reference method.
3.3.1  Instrumental precision
Then, the mean quantity value obtained from the test device 
(µ) can be derived with its variability (2σTest). This vari‑
ability, in repeatedly assessing a constant quantity value of 
the measurand, is due to random errors of measurements. 
The mean value of random error is 0 if normally distributed 
around the mean value of the measurand µ, and refers to 
as the instrumental precision of the test device. This is an 
internal instrument property that needs no reference to be 
estimated (Fig. 5).
3.3.2  Instrumental bias
The difference between µ and T evaluates the systematic 
error of the tested device indications and refers to as instru‑
mental bias. The uncertainty on the systematic error depends 
on the respective SEMs, and thus on the confidence inter‑
val attributed to the reference method and to the confidence 
interval attributed to the test device (Fig. 6). The signifi‑
cance of the mean difference (instrumental bias) may be 
tested using a Welch’s t test. Indeed, the Student’s t test (and 
ANOVA) assumes that the two populations have normal dis‑
tributions with equal variances. The Welch’s adaptation is 
designed for unequal variance still with the assumption of 
normality.
3.3.3  Sensitivity
Once these properties have been studied for one central value 
of the measurand, other values of the measurand must be 
tested, preferably the minimum and the maximum values of 
the prescribed measuring interval. For example, if we imag‑
ine that the measurand studied in Fig. 6 is cardiac output, 
other experiments must be done to verify the instrumental 
precisions and biases for low and high values (for example 
cardiac output = 1.5 and 4.5 L/min). This allows estimating 
the sensitivity and linearity of the test device (Fig. 7).
3.3.4  Uncertainty
Figure 7 shows a set of experiments on the same patient, 
in the same location, with the same investigator, and the 
same device. Adding more diversity in each of the three 
last variables will enlarge the area of imprecision which 
is referred to as reproducibility of measurements. Add‑
ing more than one patient (referred to as the inter‑patient 
variability) represents another source of variability to the 
device uncertainty. Since it is quite difficult to imagine the 
validation of a single device, covering the whole meas‑
uring interval (at least three sets of measurements) in a 
given patient, it is impossible to test different investigators, 
different devices, and different locations (reproducibil‑
ity) on the same patient. That’s why we are often limited 
to test a technology using different devices, in different 
locations, calibrated with different chains, compared to 
different references, with different investigators, and in 
different patients. In that suboptimal situation, each piece 
of diversity adds its own variability and it becomes criti‑
cal (even inappropriate) to speak of the instrumental bias 
0 
1 
2 
3 
4 
5
+2σ
-2σ
Indicaon
Experiments
Fig. 5  Schematic representation of instrumental precision by the vari‑
ability of 15 cardiac output indications due to random errors. This 
dispersion is centered with the mean value without any need for a ref‑
erence
Journal of Clinical Monitoring and Computing 
1 3
or the instrumental precision of a technology. It would 
be preferable to use the general term of uncertainty, with 
its systematic component and variability, and its random 
component and variability (Table 1). Moreover, since it 
is often difficult to manipulate the physiologic variable 
(measurand) of a patient, the whole measuring interval 
may be investigated using the inter‑patient physiological or 
pathological variability. Paired measurements of the meas‑
urand using a reference method and a device to be tested 
may be pooled together, coming from different patients, 
locations, investigators, devices, etc. A regression line 
between the reference and the test device, or a modified 
Bland and Altman representation may be used, plotting on 
the y‑axis the difference between the reference and the test 
devices but only the reference value on the x‑axis, since it 
is supposed to represent the true value (Fig. 8) [4].
The step response time validation requires a constant 
quantity of the measurand, followed by a sudden change 
(preferably instantaneous) at a known start time. In clinical 
practice, this sudden change may not be easy to provoke 
and to prove. Natural changes can be used if the test device 
can be compared with a reference method with a known 
fast response time. The reference method for validating the 
step time response of a measuring device may be different 
than the reference method for measurements. For example, 
for validating the step response time of a device measuring 
cardiac output, fast changes in mixed venous blood oxygen 
saturation  (SvO2) or invasive blood pressure can be chosen 
Fig. 6  Comparison of a test device for measuring cardiac output 
against a reference method. In this example, it was chosen to collect 
the same number of measurements (15) using the reference method 
and using the test device (left panel table). On the right the corre‑
sponding frequency distributions with a step = 0.1 is shown (reference 
in red and test device in blue). Also figures are the normal adjustment 
(plain curve), the mean value (dotted line), and the 95% confidence 
interval (± 2SEM area around the mean value). In this example, the 
systematic error (instrumental bias) is 0.63, the uncertainty on this 
systematic error is given by the formula  (SEMref2 +  SEMTest2)0,5 = 
0.33, and the confidence interval [0.31–0.96], being significant with 
p < 0.001 using a Welch’s t test
∆1
indicaon
∆1
measurand
∆2
indicaon
∆2
measurand
Identy line 
slope = 1
Tested device
Reference method
Fig. 7  Comparison between the test device and the reference method, 
based on three sets of paired measurements representing the whole 
measuring interval of cardiac output (1.5–4.5 L/min). Purple areas 
show the uncertainty as derived by the reference 2 SEM on the x‑axis 
and the test device 2 SEM on the y‑axis. The data of the central point 
are those shown in Fig.  5. In this example, the precisions of both 
technologies remain constant over the measuring interval (same pur‑
ple areas). The test device shows a good sensitivity (Δ1 indication/Δ1 
measurand = Δ2 indication/Δ2 measurand = 1) with a regression curve 
(purple dotted line) close to the perfect identity shown by the red dot‑
ted line. Therefore, the instrumental bias shown by the test device is 
constant (offset)
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as the reference if other components than  SvO2 and blood 
pressure can be stabilized.
3.3.5  Stability
Although instrumental drift is easy to evidence, stability 
may affect all properties of a measuring device and con‑
tributes to the uncertainty of measurements. A complete 
-2 
-1,5 
-1 
-0,5 
0 
0,5 
1 
1,5 
0 1 2 3 4 5 6 7 
+2σ
-2σ
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4 
5 
6 
7 
0 1 2 3 4 5 6 7 
Identy line
Slope = 1
Slope = 0.8
Difference Tested
Reference Reference
Fig. 8  On the left panel a modified Bland & Altman representation 
is shown. One hundred inter‑ and intra‑patients paired measure‑
ments are reported. In this example, indicating the mean bias and 
the variability of the bias, the instrumental bias of the test device is 
decreasing from low to high values of the measurand. In addition, the 
uncertainty (combining imprecision, non‑sensitivity, and interpatient 
variability of the bias) is increasing proportionally to the value of 
the measurand. On the right panel, same data reported on a regres‑
sion plot showing the same non‑idealities (with different scales). The 
imperfect sensitivity is shown by a regression slope < 1 and indicates 
the need for a better gain
Table 1  Same comparison than in Fig. 6 (with low, medium and high values of the measuring interval) in three different hypothetical patients 
where constant random and systemic errors have been computed
Low Medium High
Systematic Patient 1 0.53 0.54 0.60
Patient 2 0.62 0.57 0.42
Patient 3 0.44 0.41 0.64
Low Medium High
Random Patient 1 0.27 0.29 0.34
Patient 2 0.34 0.29 0.23
Patient 3 0.28 0.27 0.32
low ref low test med ref med test high ref high test low ref low test med ref med test high ref high test low ref low test med ref med test high ref high test
1 1,13 1,82 2,63 3,57 4,13 5,23 1,91 2,11 2,65 3,72 4,43 5,14 1,73 2,19 3,38 3,62 4,38 4,91
2 1,38 1,95 2,88 3,64 4,38 5,12 1,22 1,90 3,01 3,33 4,76 4,81 1,08 1,90 3,36 3,28 4,49 5,21
3 1,24 1,84 2,74 3,38 4,24 4,87 1,76 1,84 3,14 3,70 4,76 4,89 1,80 2,14 3,10 3,51 4,65 5,21
4 1,68 2,11 3,18 3,66 4,68 4,76 1,21 2,18 2,65 3,66 4,81 4,85 1,59 1,93 3,26 3,59 4,05 4,98
5 1,81 1,83 3,31 3,53 4,81 5,14 1,09 2,16 3,20 3,52 4,63 5,06 1,50 1,97 3,26 3,54 4,47 5,23
6 1,66 1,88 3,16 3,27 4,66 4,85 1,77 2,12 3,37 3,66 4,32 4,99 1,88 2,21 2,82 3,56 4,14 5,05
7 1,64 2,01 3,14 3,51 4,64 5,08 1,76 1,79 2,61 3,32 4,27 4,86 1,92 2,01 2,70 3,56 4,22 4,96
8 1,16 2,10 2,66 3,35 4,16 5,15 1,61 2,16 3,41 3,60 4,34 4,94 1,68 2,03 2,82 3,29 4,89 4,76
9 1,47 2,16 2,97 3,59 4,47 5,01 1,48 1,82 3,32 3,70 4,78 4,89 1,27 2,16 3,05 3,54 4,23 5,19
10 1,57 1,96 3,07 3,25 4,57 5,01 1,15 2,12 3,21 3,71 4,25 4,99 1,88 1,82 3,17 3,56 4,31 5,13
11 1,42 2,02 2,92 3,46 4,42 5,23 1,05 2,21 2,70 3,68 4,68 5,02 1,51 1,82 2,91 3,31 4,24 5,12
12 1,75 2,16 3,25 3,65 4,75 5,25 1,18 2,03 2,96 3,62 4,23 4,92 1,34 2,20 2,84 3,36 4,48 4,96
13 1,19 1,75 2,69 3,40 4,19 4,76 1,25 2,22 3,19 3,42 4,87 4,92 1,26 1,84 2,81 3,63 4,17 4,81
14 1,13 2,11 2,63 3,40 4,13 5,24 1,74 1,76 2,72 3,66 4,94 5,22 1,66 2,02 3,22 3,29 4,67 5,04
15 1,57 2,03 3,07 3,70 4,57 5,07 1,18 2,19 3,02 3,41 4,22 5,07 1,66 2,09 3,17 3,37 4,40 4,81
mean 1,45 1,98 2,95 3,49 4,45 5,05 1,42 2,04 3,01 3,58 4,55 4,97 1,58 2,02 3,06 3,47 4,39 5,03
2sd 0,47 0,27 0,47 0,29 0,47 0,34 0,61 0,34 0,57 0,29 0,53 0,23 0,51 0,28 0,45 0,27 0,46 0,32
2se 0,24 0,14 0,24 0,15 0,24 0,18 0,31 0,18 0,29 0,15 0,27 0,12 0,26 0,14 0,23 0,14 0,24 0,16
patient 1 patient 2 patient 3
All data are shown in the top table. The averaged results are summarized in the tables below. According to the patient and to the level of the 
measurand, the systemic bias ranges from 0.42 to 0.64 (global mean = 0.53 ± 0.09) and the random error ranges from 0.23 to 0.34 (global mean 
= 0.29 ± 0.04). This validation procedure, if real, would have shown that any change over the measuring interval of the test device >0.33 is real 
and not due to chance alone; also that there is a constant offset that must be corrected for
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analysis of stability requires restarting the validation process 
after a certain delay to verify that the same performances 
are obtained. The specified period of time where the sta‑
bility must be checked depends on the measurand and on 
the clinical use of the measuring device, ranging from sev‑
eral hours (blood pressure,  SpO2,  SvO2, cardiac output) to 
months (blood gas analyzers, thermometers, mechanical 
ventilators, …). This is easier when the measurand is well 
known (coming from a bench or a calibrated device). When 
the validation process involves real patients, the inter‑patient 
variability necessarily enlarges the uncertainty and may hide 
a small systematic drift.
4  Practical considerations for validations 
procedures
Providing specific recommendations how to plan, perform, 
analyze, and report method comparison studies in periop‑
erative and intensive care medicine is far from being trivial 
because different variables (measurands) assessed in these 
settings have distinctly different properties, dynamics, nor‑
mal ranges etc. Therefore, when analyzing the agreement 
between a test method and a reference method, specific 
aspects must be considered depending on the measurand of 
interest. For example, evaluating the agreement between two 
methods for the measurement of blood glucose [5] requires 
different statistical tests than comparing methods for blood 
pressure [6] or cardiac output [7].
Giving recommendations on how to perform valida‑
tion procedures and method comparison studies for vari‑
ous different variables used in perioperative and intensive 
care medicine is beyond the scope of this article. Neverthe‑
less, we want to emphasize that the metrological terms and 
definitions described in the article are not only theoretical 
concepts but concepts that are essential when performing 
and reporting validation studies. For instance, cardiac out‑
put is a key variable in the treatment of high‑risk surgical 
patients and critically ill patients with circulatory shock, 
and there are different methods to assess cardiac output in 
clinical practice [8]. Let’s suppose that we want to evalu‑
ate a method (test method) for cardiac output as measurand 
and describe its measurement quality criteria. The following 
metrological concepts should be considered and reported in 
order to adequately report research results in cardiac output 
validation studies.
4.1  Instrumental precision of test method (random 
error)
• On a unique patient in a steady state, collect as much 
as possible repeated indications using the test method 
during a short period of time. Since during this short 
period of time, the true cardiac output is supposed to be 
relatively constant, the 2σ and 2σ/µ of the test method 
indications estimate the random error of measure‑
ment (repeatability). However, even in clinically stable 
patients, the true value of any hemodynamic variable is 
never completely constant over several cardiac and res‑
piratory cycles. Therefore, from a strict statistical point 
of view, we have to deal with repeated measurements of 
multiple (changing) true values and not with repeated 
measurements of a single (constant) true value [3].
• Then, restart the same process with different patients for 
deriving the inter‑patient random error as mean 2σ’ and 
mean 2σ’/µ’ (intermediate precision).
• Then, in theory, one may restart with different opera‑
tors and different devices for deriving the inter‑operator, 
and inter‑device random error as mean 2σ’’ and mean 
2σ’’/µ’’ (reproducibility).
4.2  Instrumental bias of test method (systematic 
error)
• Choose a reference method with a  2SEMref ideally < 2σ/4. 
For example, if the test method precision obtained in step 
1 is 2σ/µ = 16%, the reference method should reach at 
least a  SEMref of 4%. Hence, if a continuous thermodilu‑
tion method with 2σ/µref = 20% is chosen as reference 
method for measuring cardiac output, then 25 measure‑
ments (indications) should be obtained (since 20/
√
25 = 
4). If a bolus thermodilution method with 2σ/µref = 10% is 
chosen as reference method, then 6 measurements should 
be obtained (since 10/
√
6 = 4). If a steady state cannot be 
obtained during the period of time necessary to collect 
the appropriate number indications, another reference 
method must be found.
• Compare the test method indications and the reference 
method indications for at least one low, one medium, 
and one high value of cardiac output. Then derive the 
slope and compare it with the identity line (sensibility 
and linearity).
• Repeat this procedure in a series of different patients to 
derive the mean bias, mean sensitivity, and mean linear‑
ity and their variabilities.
4.3  Step response time
• Choose a reference method with a fast step response time 
for measuring cardiac output (not necessarily the same 
method used for point 2). Indeed, the reference method is 
not only specific of the measurand but also of the quality 
criteria. Therefore, any hemodynamic variable closely 
linked to cardiac output with a very good step response 
time can be used to study the time delay of a cardiac 
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output indication, if physiologically linked, for example 
invasive arterial blood pressure. Of course, during the 
short time of the experiment, other components of the 
blood pressure must be constant.
• Choose as start time the sudden change in blood pressure 
following a sudden hemodynamic intervention (for exam‑
ple a lung recruitment test with high level of PEEP). This 
change is also indicative of the cardiac output change.
• Measure the time delay between the change in blood 
pressure and the change of the test method indication.
• Repeat this in a series of different patients to derive the 
mean time and variability.
4.4  Stability of precision, trueness, and step 
response time
• Restart 2), 3) and 4) during a specified period of time 
to evidence an eventual drift in the quality criteria men‑
tioned above.
5  Conclusions
In perioperative and intensive care medicine, a specific inde‑
pendent evaluation of metrological properties is not actually 
mandatory as of yet. One of the reasons may be the lack of 
consensus among physicians, scientists, and scientific socie‑
ties on which are the recommended qualification procedures. 
Recently, the European Union published a new directive on 
medical devices [9], focusing mainly on safety. However, it 
is mentioned that in the case of devices with a measuring 
function, the notified body is involved in all aspects relat‑
ing to the conformity of the device with the metrological 
requirements [9]. In addition, the rules on clinical investiga‑
tions should be in line with well‑established international 
guidance in this field such as the International Organization 
of Standardization (ISO) or Good Clinical Practice (GCP). 
In line with these recommendations, the international scien‑
tific societies of other medical specialties have established 
metrologic standards. International societies of perioperative 
and intensive care medicine should start the same process.
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